Assessment of the relative in vivo potency of the hydroxylated metabolite of darifenacin in its ability to decrease salivary flow using pooled population pharmacokinetic–pharmacody...

par Kerbusch, Thomas, Milligan, Peter A, Karlsson, Mats O
Publié 2004

Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies

par Karlsson, Mats O., Lutsar, Irja, Milligan, Peter A.
Publié 2009

A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction

par Milligan, Peter A, Marshall, Scott F, Karlsson, Mats O
Publié 2002

Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulatio...

par Kerbusch, Thomas, Wählby, Ulrika, Milligan, Peter A, Karlsson, Mats O
Publié 2003

Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis

par Wählby, Ulrika, Thomson, Alison H, Milligan, Peter A, Karlsson, Mats O
Publié 2004

Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children

par Walsh, Thomas J., Driscoll, Timothy, Milligan, Peter A., Wood, Nolan D., Schlamm, Haran, Groll, Andreas H., Jafri, Hasan, Arrieta, Antonio C., Klein, Nigel J., Lutsar, Irja
Publié 2010